New genome-wide methods bring more power to yeast as a model organism

Author： Game J.C.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.23, Iss.10, 2002-10, pp. : 445-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genome-wide studies in pharmacogenomics: harnessing the power of extreme phenotypes

By Gurwitz David   McLeod Howard L  

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 337-339

Future Medicine

Access to resources Recommend Favorite

Yeast as a Humanized Model Organism for Biotransformation-Related Toxicity

By  

Current Drug Metabolism, Vol. 13, Iss. 10, 2012-01 ,pp. : 1464-1475

Bentham Science Publishers

Access to resources Recommend Favorite

Genome-wide Analysis of Myelodysplastic Syndromes

By  

Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. : 3163-3169

Bentham Science Publishers

Access to resources Recommend Favorite

Rare-variant genome-wide association studies: a new frontier in genetic analysis of complex traits

By Wagner Michael J  

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 413-424

Future Medicine

Access to resources Recommend Favorite

Breaking new ground in inflammatory bowel disease genetics: genome-wide association studies and beyond

By Imielinski Marcin   Hakonarson Hakon  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 663-665

Future Medicine

Access to resources Recommend Favorite